Bumetanide Tablet
Product Images NDC 70518-4387

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 70518-4387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical structure of the active ingredient bumetanide, showing its molecular arrangement including carboxyl, sulfonamide, and phenoxy groups attached to a benzene ring.*

FDA Label Image

Remedy_label (Remedy Label)

Bumetanide 2 mg oral tablets, pack of 90, repackaged by RemedyRepack Inc. The label shows tablet is round and brown with identifier E;130. Manufacturer is Sandoz Inc., Princeton, NJ. Storage instructions and medication warnings are present. NDC 70518-4387.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.